News

Filter

Current filters:

apaziquone

Spectrum plunges on negative trial results; makes bid for Allos

10-04-2012

US biotech firm Spectrum Pharmaceuticals (Nasdaq: SPPI) saw its shares plunge as much as 14%, before…

Allos TherapeuticsapaziquoneBiotechnologyFolotynMergers & AcquisitionsOncologyPharmaceuticalResearchSpectrum Pharmaceuticals

COMPANY SPOTLIGHT

Menarini

Back to top